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Background: The selection of stable and suitable reference genes for real-time quantitative PCR (RT-qPCR) is a
crucial prerequisite for reliable gene expression analysis under different experimental conditions. The present study
aimed to identify reference genes as internal controls for gene expression studies by RT-qPCR in azole-stimulated
Candida glabrata.
Results: The expression stability of 16 reference genes under fluconazole stress was evaluated using fold change
and standard deviation computations with the hkgFinder tool. Our data revealed that the mRNA expression levels
of three ribosomal RNAs (RDN5.8, RDN18, and RDN25) remained stable in response to fluconazole, while PGK1,
UBC7, and UBC13 mRNAs showed only approximately 2.9-, 3.0-, and 2.5-fold induction by azole, respectively. By
contrast, mRNA levels of the other 10 reference genes (ACT1, EF1α, GAPDH, PPIA, RPL2A, RPL10, RPL13A, SDHA, TUB1,
and UBC4) were dramatically increased in C. glabrata following antifungal treatment, exhibiting changes ranging
from 4.5- to 32.7-fold. We also assessed the expression stability of these reference genes using the 2-ΔΔCT method
and three other software packages. The stability rankings of the reference genes by geNorm and the 2-ΔΔCT
method were identical to those by hkgFinder, whereas the stability rankings by BestKeeper and NormFinder were
notably different. We then validated the suitability of six candidate reference genes (ACT1, PGK1, RDN5.8, RDN18,
UBC7, and UBC13) as internal controls for ten target genes in this system using the comparative CT method. Our
validation experiments passed for all six reference genes analyzed except RDN18, where the amplification efficiency
of RDN18 was different from that of the ten target genes. Finally, we demonstrated that the relative quantification
of target gene expression varied according to the endogenous control used, highlighting the importance of the
choice of internal controls in such experiments.
Conclusions: We recommend the use of RDN5.8, UBC13, and PGK1 alone or the combination of RDN5.8 plus UBC13
or PGK1 as reference genes for RT-qPCR analysis of gene expression in C. glabrata following azole treatment. In
contrast, we show that ACT1 and other commonly used reference genes (GAPDH, PPIA, RPL13A, TUB1, etc.) were not
validated as good internal controls in the current model.
Keywords: Candida glabrata, Azole resistance gene, Fluconazole, hkgFinder, Housekeeping gene, Reference gene,
RT-qPCR* Correspondence: liquenti@niaid.nih.gov
1Clinical Mycology Section, Laboratory of Clinical Infectious Diseases, National
Institute of Allergy and Infectious Diseases, National Institutes of Health,
Bethesda, MD 20892, USA
Full list of author information is available at the end of the article
© 2012 Li et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Li et al. BMC Molecular Biology 2012, 13:22 Page 2 of 13
http://www.biomedcentral.com/1471-2199/13/22Background
The investigation of gene expression has become in-
creasingly prevalent in numerous animal, human, micro-
organism, and plant studies [1-5]. The quantitation of
gene expression requires sensitive, precise, and reprodu-
cible measurements for specific mRNA sequences. Gen-
erally, gene expression levels can be determined by a
variety of techniques, including Northern blotting,
RNase protection assay, semi-quantitative reverse-tran-
scription PCR, and real-time quantitative PCR (RT-
qPCR) [4]. RT-qPCR has gained favor as it is a highly
sensitive, accurate, and fast technique that offers high-
throughput and the ability to detect low-abundance
mRNAs [6] and quantify mRNA copy number [7]. Thus,
RT-qPCR has been used for countless different applica-
tions [1-5].
One of the main uses of RT-qPCR, when coupled with
reverse transcription, is to measure gene expression at
the mRNA level in various biological samples. However,
there is substantial technical variability associated with
RT-qPCR, arising from inherent differences in samples,
sample collection, RNA degradation and extraction effi-
ciency, quantity and quality of input RNA, reverse tran-
scription and PCR efficiency, and pipetting accuracy or
error. Researchers have employed a number of strategies
to normalize their data, including normalization to (i)
genomic DNA, (ii) total RNA, (iii) an external standard,
and (iv) a reference gene. The most common practice is
to normalize to an internal control gene termed a refer-
ence gene. A reference gene is subject to the same errors
in cDNA preparation as the gene of interest, making it
an excellent normalizing control. However, selection of
an inappropriate reference gene can add large unpredict-
able error to the analysis and result in incorrect esti-
mates [8]. The ideal reference gene should have a stable
RNA transcription level under different experimental
conditions and be sufficiently abundant across different
tissues and cell types. However, it has become apparent
that such an ideal reference gene has not yet been iden-
tified [9]. The most commonly used reference genes, in-
cluding β-actin, cyclophilin, GAPDH, tubulin, and 18S
and 28S ribosomal RNAs, have shown variable expres-
sion levels in different cells and tissues under different
conditions, and therefore they are unsuitable forTable 1 Candida glabrata strains used in this study
Strain Parental strain Genotype or descri
NCCLS84 Wild-type (ATCC9003
Cg84u NCCLS84 Δura3
CgB4 Cg84u Δura3 ΔCgpdr1::Tn5 <
Cg3S Clinical susceptible is
Cg4R Clinical resistant isola
*American Type Culture Collection, Manassas, VA, USA.normalization purposes owing to large measurement
error [6,10-33]. Hence, it is no longer acceptable to arbi-
trarily select any reference gene for normalization; it
must be demonstrated that the reference gene of choice
is suitable for the experiment in question.
In recent decades, Candida glabrata has emerged as
the second most common cause of invasive fungal infec-
tion [1,34,35]. Azoles such as fluconazole are the first-
line drugs for the treatment of fungal infections caused
by C. glabrata. However, resistance to azoles can arise
rapidly in C. glabrata during treatment of patients with
azoles [36]. An increasing body of evidence has impli-
cated ATP-binding cassette transporters (e.g., Cdr1 and
Pdr1) and sterol biosynthetic enzymes (e.g., Erg3 and
Erg11) in azole resistance in C. glabrata in both clinical
and laboratory settings [1,34-37]. The expression of
these genes in C. glabrata in response to azoles is not
completely understood. Therefore, we set out to estab-
lish an in vitro model for investigating azole-inducible
gene expression in C. glabrata, using RT-qPCR. For reli-
able gene expression analysis, a compulsory step is the
selection of good reference genes for normalization;
however, no validated reference genes have been
reported for the relative quantification of the mRNA ex-
pression profile in C. glabrata following exposure to
azoles.
We have been using ACT1 as the internal control for
gene expression analysis by RT-qPCR in clinical isolates
of C. glabrata in the absence of drug challenges [1].
Other researchers also use ACT1 as the reference gene
for azole-inducible gene expression studies by slot blot-
ting in Candida species [34,37,38]. However, the suit-
ability of ACT1 in studies of azole-inducible gene
expression in C. glabrata has not been validated. In this
work, we evaluated 16 reference genes to establish their
suitability as control genes for normalization and identi-
fied a set of genes that are suitable for quantitative gene
expression analysis by RT-qPCR in C. glabrata following
fluconazole treatment.
Methods
Cell culture and drug treatment
All five C. glabrata strains (Table 1) used in the present
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ura3 mutant Cg84u did not grow in minimal (MIN)
medium, unless supplemented with 20 μg/ml of uracil
(Sigma-Aldrich, St. Louis, MO, USA).
Fluconazole (Euroasian Chemicals Private Ltd., Fort,
Mumbai, India) was added to cultures of each strain at a
final concentration of 200 μg/ml, followed by continued
incubation with shaking for 2 h. Cell cultures without
fluconazole treatment served as controls.
The susceptibility of each C. glabrata strain to fluco-
nazole was determined on YPD agar medium using an
E-test (AB Biodisk, Solna, Sweden) according to the
manufacturer’s instructions (Table 1).
RNA isolation and reverse transcription
Total RNA was extracted from C. glabrata logarithmic-
phase cultures grown in YPD broth, using TRIzol re-
agent (Invitrogen, Life Technologies, Grand Island, NY,
USA) according to the manufacturer’s instructions. The
concentration and purity of the RNA was determined
using a UV spectrophotometer (NanoDrop 2000C; Ther-
moFisher Scientific, Waltham, MA, USA) by measuring
the absorbance at 230 (OD230), 260 (OD260) and 280 nm
(OD280). The OD260nm/OD280nm of the samples, reflect-
ing the average purity, ranged from 1.80 to 2.05, and the
OD260nm/OD230nm was in the range of 2.00–2.60. The
integrity of the RNA was further checked in a selected
subset of samples by electrophoresis through 1% de-
naturing and non-denaturing agarose gels.
Reverse transcription (RT) was performed on 1 μg of
total RNA using a commercially available kit. Prior to
RT, the total RNA samples were treated with DNase for
30 min at 37°C (TURBO DNA-free; Ambion, Life Tech-
nologies, Grand Island, NY, USA) according to the man-
ufacturer’s instructions. RNA was converted to cDNA
using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems, Life Technologies, Carlsbad,
CA, USA). The reaction took place in a thermal cycler
(T3 Thermocycler; Biometra, Goettingen, Germany)
with a single cycle and incubation periods of 25°C for
10 min, 37°C for 120 min, and 85°C for 5 min. All inves-
tigated samples were transcribed with the same reverse
transcription reaction conditions. Negative controls,
which were run simultaneously, did not contain either
RNA (no template control) or no reverse transcriptase
(RT negative control), to control for RNA and genomic
DNA contamination, respectively.
Primer and probe design
Primers and probes were designed in our laboratory
using the primer analysis software Primer Express 3.0
(Applied Biosystems). TaqMan probes were synthesized
by Applied Biosystems, and primers were synthesized by
Invitrogen/Life Technologies. The primers and TaqManprobes used in the current study were selected to bind
specifically to the cDNAs of Cg84u and other C. glab-
rata strains (Table 1). The sequences of TaqMan probes
and forward and reverse primers, the gene numbers, and
the localization for each PCR assay for the 16 reference
genes and 10 target genes assessed in this study are
listed in Additional file 1, Additional file 2, and
Additional file 3.RT-qPCR analysis
RT-qPCR for reference gene RNA transcription was per-
formed by SYBR Green chemistry (SYBR Green PCR
Master Mix; Applied Biosystems). The increase in fluor-
escence of the SYBR Green dye was monitored using a
7500 Real-time PCR System (Applied Biosystems). This
technique has been successfully used to validate refer-
ence gene expression levels in yeast and other cell types
[41]. Primers were used at 300 nM each for specific for-
ward and reverse primers and cDNA at 25 ng in 25-μl
reactions. Primer sets for the reference genes (Additional
file 2) were used to amplify the open reading frame
(ORF) region of the genes according to the following
conditions: one cycle of 50°C × 2 min, 95°C × 10 min; fol-
lowed by 40 cycles of 95°C × 15 s, 60°C × 1 min; with dis-
sociation (a melting curve) during the last cycle of 95°
C × 15 s, 60°C × 1 min, 95°C × 15 s. The dissociation
protocol to determine the melting curve from 60°C to
95°C for each PCR product was added after thermocy-
cling to verify that each primer pair produced only a sin-
gle product. All samples gave only a single peak,
indicating a single pure product and no primer/dimer
formation. Real-time PCR efficiencies were acquired by
amplification of a standardized dilution series of the
template cDNA and were determined for each gene as
the slope of a linear regression model. PCR efficiency
was determined by measuring the CT to a specific
threshold for a serial dilution of cDNA. The correspond-
ing real-time PCR efficiencies were then calculated
according to the equation: E ¼ 101=slope  1  100 .
All PCRs displayed efficiencies between 94% and 119%.
To study target gene expression, the amplification was
detected in real time using TaqMan chemistry (TaqMan
Universal PCR Master Mix; Applied Biosystems) accord-
ing to the manufacturer’s instructions. RT-qPCR was
performed in 96-well microtiter plates with a final vol-
ume of 25 μl, using a 7500 Real-time PCR System (Ap-
plied Biosystems). Primers were used at 300 nM each for
specific forward and reverse primers; probes, at 200 nM;
and cDNA, at 25 ng in 25-μl reactions. Primer sets and
TaqMan probes for the target genes (Additional file 3)
were used to amplify the ORF region of the genes under
the following conditions: one cycle of 50°C × 2 min, 95°
C × 10 min; and then 40 cycles of 95°C× 15 s, 60°
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ence genes and the target genes was confirmed for each
with probe-primer sets. To minimize technical (run-to-
run) variation between the samples, all samples were
analyzed in the same run for both target genes and refer-
ence genes.
Evaluation of reference gene expression stability using
four different software packages
Non-normalized gene expression levels from our experi-
mental data were analyzed to evaluate the expression
stability of potential reference genes, using four different
software programs: hkgFinder [42], geNorm [9,43], Best-
Keeper [44], and NormFinder [26]. The hkgFinder soft-
ware computes the pooled standard deviation (SD) of
non-normalized expression data from both phenotypes
(i.e., azole-treated and untreated C. glabrata cells), the
fold change (FC) values between the two phenotypes,
and Student’s t-tests of the log2 fold-change values with
Holm-adjusted P-values. The reference genes with the
smallest SD and the smallest, non-significant FC are
identified as the best potential reference genes (Add-
itional file 4). The geNorm software computes a stability
value (M) and a pairwise variation (V), which are used
to evaluate each individual reference gene candidate or
each combination of reference genes, called a
normalization factor (NF). The pairwise variability V of
two genes j and k is the standard deviation of all log2
ratios of aj/ak, while the stability value M of gene j is the
mean of all possible pairwise variations Vjk. Graphs of
the M values help identify the best individual reference
genes, and graphs of the V values identify the optimal
number of reference genes for an NF. Note that an earl-
ier version called geNorm Excel was produced as an
add-in for MS Excel and it required several hand calcu-
lations to convert crossing point (CP) values into relative
expression values. That version is now unavailable and
the new geNorm PLUS from Biogazelle does not require
those hand calculations. The BestKeeper software uses
pairwise correlation to determine whether potential
reference genes should be included in a BestKeeperTable 2 Stability of RNA transcription of reference genes in fl
method
RDN18 RDN25 RDN5.8 UBC13 PGK1 UBC7 GAPDH
CT Change 0.34 0.39 0.46 1.34 1.56 1.60 2.17
ΔΔCT(t) 0.12 0.07 0 -0.87 -1.10 -1.13 -1.71
2-ΔΔCT(t) 0.92# 0.95# 1.00 1.83* 2.14* 2.19* 3.28*
Ranking 1 2 3 4 5 6 7
CT Change = CT(ut) −CT(t); ut, untreated; t, fluconazole-treated.
ΔCT = CT reference−CT RDN5.8; ΔCT of each reference gene was calculated using RDN5.8
ΔΔCT(t) =ΔCT(t)−ΔCT(ut).
2-ΔΔCT(t) for fluconazole-treated cells indicates fold change in RNA transcription of a
The stability ranking is based on the values of CT Change, ΔΔCT(t), and 2
-ΔΔCT(t) of t
#P> 0.05 and *P< 0.05 for the azole-treated group vs. the untreated group after norIndex, which is simply the geometric mean of the CP or
cycle threshold (CT) values. The NormFinder software
computes a different type of stability value (ρig) based on
the intragroup and intergroup variation of the expres-
sion data. The software instructions from each package
were followed when inputting the RT-qPCR data, fetch-
ing the output, and interpreting the analysis results.
Results
Stability of RNA transcription of reference genes in C.
glabrata following azole stimulation
In the present study, 16 reference genes were chosen
from among commonly used reference genes in pub-
lished studies with yeast and mammalian cells, paying
close attention to selecting genes that belong to different
functional classes; their full names, symbols, functions,
and gene numbers are listed in Additional file 1. Our
aim was to identify reference genes with minimal vari-
ability under our experimental conditions. To this end,
RT-qPCR was used to measure the RNA transcription
levels of 16 reference genes in C. glabrata cells following
fluconazole treatment. To compare the different RNA
transcription levels after azole exposure, the CT values of
the reference genes were directly compared between the
drug-treated (t) and untreated (ut) samples using the
formula: CT Change =CT(ut)−CT(t). The CT is defined
as the number of cycles needed for the fluorescence sig-
nal to reach a specific threshold level of detection and is
inversely correlated with the amount of template cDNA
present in the reaction. Thus, a higher value of CT
Change indicates lower stability of a reference gene, con-
sidering that the expression of a reference gene should
not change significantly with azole treatment. As
expected, the RNA transcription levels of the reference
genes varied (Table 2). The three ribosomal RNA subu-
nits RDN5.8, RDN18, and RDN25 were the most stable
reference genes, with CT Change values less than 0.5,
while UBC13, PGK1, and UBC7 were relatively stable
with CT Change values of only around 1.5. By contrast,
the other 10 reference genes showed marked variation in
response to fluconazole. Among them, the mostuconazole-treated C. glabrata as determined by the 2-ΔΔCT
UBC4 TUB1 EF1α PPIA RPL2A RPL10 RPL13A ACT1 SDHA
2.41 2.60 2.89 3.13 3.67 4.12 4.17 4.45 5.03
-1.95 -2.13 -2.43 -2.66 -3.21 -3.65 -3.71 -3.98 -4.57
3.86* 4.39* 5.38* 6.32* 9.23* 12.58* 13.06* 15.82* 23.75*
8 9 10 11 12 13 14 15 16
as the internal control.
reference gene normalized to RDN5.8, as compared with untreated cells.
he reference genes in fluconazole-treated C. glabrata cells.
malizing to RDN5.8.
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levels of SDHA, ACT1, and RPL13A; as seen in Table 2,
the CT Change values of these reference genes were as
high as 5.03.
To validate the stability of candidate RNA transcrip-
tion under our experimental conditions, the levels were
compared with the RDN5.8 RNA transcription level. We
chose to use RDN5.8 as a normalizer because it meets
the requirement for both stability and suitability as a
reference. First, we calculated the ΔCT between the CT
values of reference genes and RDN5.8 from fluconazole-
treated (t) and untreated (ut) cells:
ΔCT(t) =CT(t reference)−CT(t RDN5.8) and ΔCT(ut) =
CT(ut reference)−CT(ut RDN5.8).
In the second step, we subtracted the change in RNA
transcription in untreated samples from the change in
treated samples to obtain the ΔΔCT(t):
ΔΔCT(t) =ΔCT(t)−ΔCT(ut).
Thus, ΔΔCT(t) indicates the change in RNA transcrip-
tion caused by fluconazole treatment after normalization
to RNA transcription changes in RDN5.8. A high ΔΔCT
(t) value indicates a significant fluconazole-related
change in the RNA transcription level of the tested gene.
A positive ΔΔCT(t) value indicates down-regulation of
transcription, whereas a negative ΔΔCT(t) indicates up-
regulation of a gene’s transcription following azole treat-
ment. We then transformed ΔΔCT(t) into a 2
-ΔΔCT value,
which indicates the fold change in RNA transcription of
a reference gene in response to fluconazole as compared
with the level in untreated cells. The calculated ΔΔCT(t)
and 2-ΔΔCT values of the 16 tested reference genes in
drug-treated samples are given in Table 2.
Following stimulation with fluconazole, the RNA tran-
scription of SDHA, ACT1, and RPL13A was highly regu-
lated in C. glabrata cells, with changes ranging from 13-
to 23-fold compared with transcription in the untreated
cells. There was almost no regulation of RDN5.8,
RDN18, and RDN25 RNA transcription, while PGK1,
UBC7, and UBC13 RNA transcription were only ap-
proximately 2-fold induction in response to drug treat-
ment (Table 2).Table 3 Assessment of reference gene expression stability in
RDN18 RDN25 RDN5.8 UBC13 PGK1 UBC7 GAPD
SD 0.19 0.22 0.26 0.73 0.87 0.88 1.19
Log fold change -0.35 -0.39 -0.46 -1.33 -1.56 -1.60 -2.18
Fold change 1.2 1.3 1.4 2.5 2.9 3.0 4.5
Ranking 1 2 3 4 5 6 7
The fold change shown in the table represents the difference in reference gene exp
normalization to an internal control gene.
The stability ranking is based on the values of standard deviation (SD), log fold cha
cells. The best reference genes will have the smallest SD and smallest fold-change vDetermination of reference gene expression stability by
four different specific software packages
To choose the best reference genes, the reference gene
stability was evaluated using four different software
packages: hkgFinder, geNorm, BestKeeper, and Norm-
Finder. Each of these software packages uses a slightly
different metric to evaluate the candidate reference
genes. Our goal was to compare the findings from these
four different methods and look for the best-scoring
reference genes that might be common to these different
methods.
The hkgFinder software identifies the best reference
genes by ranking the candidate genes according to their
SD and FC values (Table 3). Among the 16 potential
reference genes, the SDs ranged from 0.19 to 2.76, and
the FCs ranged from 1.2 to 32.7. The best three refer-
ence gene candidates were RDN18, RDN25, and
RDN5.8. The next three best candidate reference genes,
which also had reasonable SD and FC values, were
UBC13, PGK1 and UBC7.
The geNorm software evaluates reference genes by
their M-stability values and V-pairwise variability values.
Low M values represent more stable expression and thus
the most suitable reference genes (Figure 1). The geN-
orm analysis identified RDN18, RDN25, and RDN5.8 as
the three most stable genes; UBC13, PGK1, and UBC7
as relatively stable genes; and RPL13A, ACT1, and SDHA
as the three least stable genes under fluconazole treat-
ment in C. glabrata. Interestingly, the ranking of expres-
sion stability of the 16 reference genes was identical
between the geNorm program and the hkgFinder tool
(Figure 1; Tables 3 and 4). The geNorm program also
estimates the optimal number of reference genes that
could be used in combination as an NF value (Figure 2).
Each NF was calculated as the geometric mean of the
two most stable genes, then the pairwise variability V
was computed between NFn and NFn+ 1 for n= 2, . . .,
15. Vandesompele et al. [9] proposed 0.15 as a cutoff
value for V below which additional reference genes do
not need to be added to the NF. Adding the third gene
to the most stable two reference genes, RDN18 andfluconazole-treated C. glabrata by using hkgFinder
H UBC4 TUB1 EF1α PPIA RPL2A RPL10 RPL13A ACT1 SDHA
1.33 1.42 1.58 1.71 2.01 2.26 2.28 2.44 2.76
-2.41 -2.60 -2.89 -3.12 -3.67 -4.12 -4.17 -4.45 -5.03
5.3 6.0 7.4 8.7 12.7 17.4 18.0 21.8 32.7
8 9 10 11 12 13 14 15 16
ression between azole-treated and untreated C. glabrata without
nge, and fold change of reference genes in fluconazole-treated C. glabrata
alues.




































































Figure 1 Determination of the average expression stability (M)
of the reference genes using the geNorm program. The
reference genes were serially excluded from the analysis, with M
representing the mean pairwise variation between an individual
reference gene and all other tested reference genes. The reference
gene indicated at each point on the x-axis is the one that is to be
excluded from the following step. The most stable reference genes
are those that are still included, i.e., those that exhibit the lowest M
values. Shown is the stability ranking of the reference genes in all
samples. Genes are ranked from left to right in order of increasing







































Figure 2 Determination of the optimal number of reference
genes as internal references for normalization using geNorm
analysis. The geNorm program calculates a normalization factor
from at least two reference genes and the mean pairwise variation
(V) between every combination of sequential normalization factors
in order to determine the minimum number of reference genes
required for accurate normalization in the samples. For example, V5/
6 represents the comparison of the normalization factors from five
and six reference genes, respectively. On the left-most side is the
pairwise variation when the number of reference genes is increased
from two to three (V2/3). Stepwise inclusion of less stable genes
generates the subsequent data points. A decrease in the V value
indicates a positive effect and means that the added gene should
preferably be included for calculation of a reliable normalization
factor. The cutoff value for V, below which the inclusion of an
additional reference gene does not result in a significant
improvement of normalization, was set at 0.15. It was apparent from
the analysis of all studied samples that the combination of the two
most stable reference genes is the best option and the combination
of the five most stable reference genes is the second-best option for
accurate normalization.
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ing that it would not be necessary to include additional
reference genes for normalization; the second best
choice of reference gene combination based on geNorm
V was the top five most stable genes, i.e., RDN5.8,
RDN18, RDN25, UBC13, and PGK1. This reference gene
combination showed smaller variation than other gene
combinations, with a smaller V of 0.091 (Figure 2).Table 4 Comparison of reference gene expression stability* as determined by four different software packages
geNorm BestKeeper NormFinder hkgFinder
Gene Mean M Gene r Gene Stability value Gene Fold change
RDN18 0.042 UBC7 0.983 UBC7 0.425 RDN18 1.2
RDN25 0.050 UBC13 0.978 PGK1 0.459 RDN25 1.3
RDN5.8 0.055 PGK1 0.974 UBC13 0.460 RDN5.8 1.4
UBC13 0.357 RDN5.8 0.915 PPIA 0.534 UBC13 2.5
PGK1 0.478 RDN25 0.908 RDN5.8 0.922 PGK1 2.9
UBC7 0.500 RDN18 0.901 RDN25 0.935 UBC7 3.0
PPIA 0.849 PPIA 0.864 RDN18 0.961 PPIA 8.7
RPL13A 1.103 RPL13A 0.857 RPL13A 0.993 RPL13A 18.0
ACT1 1.167 SDHA 0.856 ACT1 1.200 ACT1 21.8
SDHA 1.258 ACT1 0.836 SDHA 1.480 SDHA 32.7
*Genes are listed from most to least stable for all four methods.
M, geNorm stability parameter. Mean M, stability value.
r, all 10 candidate reference genes were correlated and were combined to calculate the BestKeeper index, which was then used to determine the correlation
between each reference gene and the index.
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date reference gene stability according to a stability value
computed from the intragroup and intergroup expres-
sion variability. The least reliable reference genes identi-
fied by this program were RPL13A, ACT1, and SDHA,
which were identical to the worst reference genes identi-
fied by geNorm and hkgFinder analyses (Table 4). How-
ever, the ranking order of the most stable genes and the
relatively stable genes by the NormFinder program was
different from that generated by geNorm and hkgFinder
(Figure 1; Tables 3 and 4). The geNorm and hkgFinder
analyses graded RDN18, RDN25, and RDN5.8 as the
most stable reference genes, followed by UBC13, PGK1,
and UBC7 based on gene expression stability, whereas
NormFinder rated UBC7, PGK1, and UBC13 as the most
stable reference genes, followed by RDN5.8, RDN18, and
RDN25 (Figure 1; Tables 3 and 4).
Finally, the BestKeeper program was used to grade
candidate reference gene stability. This approach permits
a comparative analysis across reference genes. Ten refer-
ence genes analyzed were correlated and were combined
into an index. Subsequently, the correlation between
each reference gene and the index was calculated. The
best correlations between the reference genes and the
BestKeeper index were obtained for UBC7, UBC13, and
PGK1 (r= 0.983, 0.978, and 0.974, respectively; Table 4).
The rankings of the top three and the last three refer-
ence genes identified by the BestKeeper program were
the same as those generated by the NormFinder analysis,
although the order of stability of the other reference
genes differed slightly between the two programs
(Table 4).
Validation of six candidate reference genes using the
comparative CT method
Following the identification of the most stable reference
genes from the full gene panel of 16 genes, the compara-
tive CT method was used to validate their suitability.Table 5 Validation of reference gene suitability as an interna
efficiency between reference and target genes in fluconazole
Gene CDR1 PDH1 PDR1 SNQ2 YOR
ACT1 0.056 0.072 0.061 0.019 0.03
PGK1 0.018 0.049 0.014 0.059 0.09
RDN5.8 0.084 0.065 0.014 0.021 0.01
RDN18 0.187 0.315 0.304 0.262 0.21
UBC7 0.015 0.051 0.012 0.062 0.09
UBC13 0.069 0.051 0.028 0.035 0
Each value is the slope m of the line (Y =mx+b) of the validation experiment and r
efficiencies.
An absolute slope value <0.1 is generally used as a criterion for passing a validation
equal between the reference and target genes.
The slope m=0 indicates that the efficiencies of the two PCR reactions are equal.The comparative CT method, also referred to as the
ΔΔCT method, is a relative quantitation of gene expres-
sion between a specific target gene and a reference gene.
For the comparative CT method to be valid, the effi-
ciency of the target amplification and the efficiency of
the reference (internal control) amplification must be
approximately equal, and this must be determined in a
validation experiment.
To this end, we first determined the amplification effi-
ciency of 10 target genes (CDR1, PDH1, PDR1, SNQ2,
YOR1, ERG2, ERG3, ERG4, ERG10, and ERG11) and six
reference genes (ACT1, PGK1, RDN5.8, RDN18, UBC7,
and UBC13). Standard curves were generated by plotting
the dilutions of the cDNA of each gene against the CT
values. The linear correlation coefficient (r2) for all 10
target genes and the six reference genes ranged from
0.98 to 1.0. Based on these slopes of the standard curves,
the amplification efficiencies of the cDNA standards,
derived from the formula E = (10−1/slope −1) × 100, ranged
from 94 to 119%. The CT values of all 16 genes in the
samples were within the range of the standard curves.
Next, the ΔCT (ΔCT=CT target−CT reference) was calcu-
lated using the CT values generated from standard curve
mass points (target vs. reference gene). These ΔCT
values were then plotted versus log10 input amount of
cDNA to create a semi-log regression line. The slope of
the resulting semi-log regression line was used as a gen-
eral criterion for passing a validation experiment. In a
validation experiment that passes, the absolute value of
the slope of ΔCT versus log10 input cDNA would be
<0.1, meaning the two CT versus log10 concentration
curves are nearly parallel. As seen in Table 5, our valid-
ation experiments passed for all reference genes ana-
lyzed except RDN18, which had an absolute value >0.1
for the slopes of ΔCT versus log10 input cDNA for all 10
target genes evaluated. Thus, the amplification efficiency
of RDN18 was clearly different from that of the ten tar-
get genes, whereas the other five reference genes (ACT1,l control based on the correlation of amplification
-treated C. glabrata cells
1 ERG2 ERG3 ERG4 ERG10 ERG11
3 0.046 0.034 0.095 0.054 0.043
4 0.057 0.032 0.024 0.046 0.028
4 0.086 0.060 0.060 0.029 0.061
0 0.836 0.689 0.689 0.778 0.688
6 0.077 0.052 0.044 0.066 0.048
0.079 0.068 0.068 0.022 0.069
eflects the correlation of reference gene and target gene amplification
experiment, as it indicates that the amplification efficiency is approximately
Table 7 Comparison of the relative mRNA expression
levels* of four target genes in fluconazole-treated C.
glabrata when normalized to different reference genes
Gene CDR1 PDR1 ERG4 ERG10
ACT1 0.26 0.27 0.70 1.21
RDN5.8 4.07 4.27 11.08 19.07
PGK1 1.90 1.99 5.17 8.90
UBC13 2.23 2.33 6.06 10.43
RDN5.8+ PGK1 2.79 2.92 7.59 13.06
RDN5.8+UBC13 3.01 3.15 8.19 14.09
RDN5.8+ PGK1+UBC13 2.58 2.71 7.03 12.10
*Values indicate the fold change in RNA transcription for each target gene in
fluconazole-treated C. glabrata after normalization to one or more reference
genes, as compared with untreated cells.
ΔCT = CT target−CT reference.
ΔΔCT(t) =ΔCT(t)−ΔCT(ut); ut, untreated; t, fluconazole-treated. Fold change= 2
-
ΔΔCT(t).
Fold changes of the target genes were also computed with the hkgFinder tool
by using one or more reference genes as the internal control for normalization
P< 0.05 vs. untreated cells, for all values shown in the table after normalizing
to one or more reference genes as indicated.
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that were similar or relatively equivalent to the target
amplification efficiencies (Table 5).
Comparison of expression levels of inducible target genes
using different reference genes for normalization
To test the effect of azole on the expression of pleio-
tropic drug resistance genes in C. glabrata, we assessed
the fluconazole-induced expression of two ABC genes
(CDR1 and PDR1) and one ERG gene (ERG4) in five C.
glabrata strains, including the PDR1 mutant strain CgB4
(Table 1). For comparison, we used both RDN5.8 and
ACT1 as references for normalization. As shown in
Table 6, fluconazole markedly induced increases in
ERG4 mRNA levels in all C. glabrata strains examined
when normalized to RDN5.8. Fluconazole also signifi-
cantly increased CDR1 and PDR1 mRNA expression in
all of the strains except CgB4, consistent with the critical
role of PDR1 in azole-induced transactivation of ABC
transporter gene expression, but not ergosterol biosyn-
thesis gene expression, in C. glabrata. In contrast, when
using ACT1 as the reference gene for quantification, flu-
conazole appeared to down-regulate the expression of all
three target genes in the five C. glabrata strains
(Table 6).
Finally, we compared the fluconazole-inducibled
mRNA expression levels of four target genes (CDR1,
PDR1, ERG4, and ERG10) in C. glabrata (Cg84u strain)
after normalizing to different reference genes (ACT1,
PGK1, RDN5.8, and UBC13), individually and in pairs.
Differences in quantitation were detected according to
the reference genes used. As seen in Table 7,
normalization of the RT-qPCR data against the reference
genes suggested as optimal by the four software
packages (hkgFinder, geNorm, BestKeeper, andTable 6 Comparison of fluconazole-induced target gene
expression} among five different C. glabrata strains using
RDN5.8 or ACT1 as the reference for normalization
CDR1 PDR1 ERG4
Strain RDN5.8 ACT1 RDN5.8 ACT1 RDN5.8 ACT1
NCCLS84 2.12* 0.19* 2.22* 0.20* 2.85* 0.26*
Cg84u 3.90* 0.42* 3.26* 0.50* 10.04* 0.68*
CgB4 0.64# 0.06* 1.08# 0.10* 2.42* 0.22*
Cg3S 2.59* 0.23* 3.31* 0.30* 3.84* 0.35*
Cg4R 2.14* 0.19* 3.68* 0.33* 5.34* 0.48*
}Values indicate the fold change in RNA transcription for each target gene in
fluconazole-treated C. glabrata, as compared with untreated cells.
ΔCT = CT target−CT reference; ΔCT of each target gene was calculated by using
RDN5.8 or ACT1 as the reference.
ΔΔCT(t) =ΔCT(t)−ΔCT(ut); ut, untreated; t, fluconazole-treated. Fold change= 2
-
ΔΔCT(t).
Fold changes of the target genes were also computed with the hkgFinder tool
by using RDN5.8 or ACT1 as the reference.
#P> 0.05 and *P< 0.05 for the azole-treated group vs. the untreated group
after normalization to RDN5.8 or ACT1.NormFinder) or the 2-ΔΔCT method, gave comparable
relative expression levels of the target genes under fluco-
nazole treatment in C. glabrata. However, normalization
against ACT1 resulted in relative expression levels of the
targets that were substantially different from those nor-
malized using other reference genes, implying that
ACT1 is not a suitable reference gene for these studies.
Taken together with the data shown above, these results
demonstrate that the relative quantification of azole-
inducible gene expression varies largely depending on
the reference gene and the number of reference genes
used for normalization. This highlights the importance
of choosing a suitable reference gene or reference gene
pair when using RT-qPCR to determine the level of tar-
get gene expression in this model system.
Discussion
In any gene expression study, the selection of a valid
normalization or internal control gene to correct for dif-
ferences in RNA sampling is critical in order to avoid
misinterpretation of results and to obtain reliable con-
clusions. When choosing a reference gene as the internal
endogenous control for gene expression studies by RT-
qPCR, two important criteria must be met. The expres-
sion of the reference gene must remain stable through-
out the given intervention (i.e., stability), and the
amplification efficiency of the reference gene should be
similar to that of the genes of interest (i.e., suitability). In
the present study, we used five different methods to
evaluate 16 reference genes for potential use as internal
controls and found that the reference genes performed
differently in terms of stability and suitability in C. glab-
rata cells upon exposure to fluconazole. To our
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genes as RNA internal references in C. glabrata.
The poor performance of ACT1 in C. glabrata cells
was surprising, given that this gene has been used fre-
quently as the reference gene in earlier gene expression
studies [1,34,37,38]. Our data clearly demonstrate the
unsuitability of ACT1 as an internal control for gene ex-
pression studies in C. glabrata following fluconazole
treatment. The initial results gained from using ACT1 as
the internal control suggested that target gene expres-
sion was not up-regulated (Tables 6 and 7). In fact, the
only substantial change caused by azole treatment was a
greater increase in ACT1 RNA transcription compared
with target gene transcription. While these findings are
relevant to our specific study, it appears that numerous
other studies have also shown the potential of ACT1 to
detrimentally affect the accuracy of results
[11,12,15,19,26,27,29,30,32,33,45-47]. We have been
using ACT1 as the internal control for quantitation of
gene expression by RT-qPCR in clinical isolates of C.
glabrata, and we find that this gene works well as the
reference in cells without azole or other agent stimula-
tion [1]. However, Edlind and colleagues used ACT1 as
the reference gene for azole-inducible gene expression
studies by slot blotting in Candida species, and their
data clearly show the variation of ACT1 expression in re-
sponse to azoles in their systems [34,38]. Thus, our data
revealing the instability of ACT1 in C. glabrata following
antifungal treatment, combined with evidence from
mammalian and other fungus studies, add to the grow-
ing body of evidence that ACT1 expression is unstable
across various cell types and under different experimen-
tal conditions [11,12,15,26,27,29,30,32,33,45-47].
Although ACT1 gene expression was variable in re-
sponse to fluconazole, the three ribosomal RNAs (i.e.,
RDN5.8, RDN18, and RDN25) remained unaffected and
showed stable expression in azole-treated C. glabrata.
These results indicate that ribosomal RNA expression
offers superior consistency compared with the expression
of ACT1 and the other reference genes assessed. The
stable expression levels of 18S and 28S rRNAs relative to
other reference genes under a variety of experimental con-
ditions has previously been described for numerous sys-
tems, including both mammalian and yeast cells
[10,11,15,18,23,30,48-50]. The levels of ribosomal RNA,
which represents 80% of total RNA, are thought to be less
likely to vary under conditions that affect the expression
of mRNAs because they are transcribed by a distinct RNA
polymerase. As an example, Thellin et al. and other groups
have recommended the use of 18S or 28S rRNA as an in-
ternal control for mRNA quantification studies because
mRNA variations are weak and cannot highly modify the
total RNA level [10,11,15,18,30,39,48-52]. However, our
further validation experiments showed that of slopes ofΔCT versus log10 cDNA were sufficiently parallel between
RDN5.8 and the target genes, but not between RDN18 or
RDN25 and the target genes. With RDN18 and RDN25,
the absolute slope values of the ΔCT versus log10 input
cDNA lines were >0.1 for all target genes. These data indi-
cate that the amplification efficiency of RDN5.8 was simi-
lar to the efficiencies of the target genes, whereas the
amplification efficiencies of RDN18 and RDN25 were dif-
ferent from the target gene amplification efficiencies. This
may be attributable to the much higher abundance of
RDN18 and RDN25 than RDN5.8 compared with target
mRNA transcripts, making it difficult to accurately sub-
tract the baseline value in RT-qPCR data analysis. There-
fore, although all three ribosomal RNA subunits were
stable during fluconazole stimulation, only RDN5.8 may
offer a more accurate and suitable alternative to ACT1 as
an internal control for gene expression studies in C.
glabrata.
GAPDH, a glycolytic enzyme, is encoded by a single gene
and has the advantage of being highly conserved across dif-
ferent species [53,54]. Like 18S rRNA and β-actin, GAPDH
has been commonly used as an internal control, often with-
out testing. In the present study, GAPDH showed much
higher variability than any of the ribosomal RNAs in
fluconazole-treated samples. These data demonstrate that
GAPDH is not an appropriate control gene for these stud-
ies, as has been pointed out in previous examples, and that
it may lead to incorrect results under specific experimental
conditions [12-15,19,29-31,33,55]. Previous studies have
indicated the instability of GAPDH in mammalian systems,
and this study broadens the scope of this phenomenon to
C. glabrata as well.
PGK1 also plays important roles in the glycolytic path-
way, and PGK1 and GAPDH are potentially co-regulated
[56]. In our data, however, their potential co-regulation
was not significant. PGK1 mRNA levels remained rela-
tively stable, in contrast to the marked variation in
GAPDH mRNA levels in C. glabrata cells, following flu-
conazole challenge. Moreover, our comparative CT cal-
culations showed that the efficiency of PGK1
amplification was approximately equal to the efficiencies
of the target gene amplifications. Although PGK1 shows
some variation as a reference gene, this may not affect
experimental results as long as the intergroup difference
being measured is greater than the reference gene vari-
ation, that is, a reference gene RNA that has an error of
1 log2 may not be ideal, but it would be sufficient to
measure a 2 log2 change in a gene of interest. Thus, it is
inferred that PGK1 may be a suitable reference gene for
the analysis of expression for genes with higher azole-
inducible mRNA levels, such as ERG4 and ERG10.
Ubiquitin is a small regulatory protein that has been
found in almost all tissues of eukaryotic organisms. The
UBC gene codes for a polyubiquitin precursor protein
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and cells in eukaryotes, there are an increasing number
of studies in the literature using the UBC gene as the in-
ternal standard for gene expression analysis in different
eukaryotic cell systems [26,29]. Out of curiosity, we vali-
dated three UBC genes (UBC4, UBC7, and UBC13) in
this study. Interestingly, we found that UBC7 and
UBC13 mRNAs (particularly the latter) were relatively
stable in C. glabrata during fluconazole treatment. In
addition, our validation experiments demonstrated that
the amplification efficiencies of these genes were ap-
proximately equal to those of the target genes. These
findings indicate that like PGK1, UBC13 and UBC7 may
also be suitable internal controls for quantifying the ex-
pression of specific genes with higher azole-inducible
mRNA levels in C. glabrata, such as some ergosterol
biosynthesis genes.
To successfully select reference genes for our studies
involving azole treatment, we also investigated seven
other reference genes, in addition to the reference genes
mentioned above, with a diversity of functions. These
reference genes can be generally classified into several
groups: transcription-related genes (EF1α), structure/
cytoskeleton-related genes (TUB1), protein synthesis-
related genes (RPL2A, RPL10, and RPL13A), and finally,
genes that cannot be clearly categorized, including PPIA
and SDHA. These potential reference genes such as
PPIA, RPL13A, and TUB1 are other examples of com-
monly used internal controls [28,29,32]. For example,
PPIA has been used as a reference gene because of its
remarkable evolutionary conservation and broad cellular
and tissue distribution [58]. Although these seven refer-
ence genes have been used as internal standards for
normalization in countless studies, all of these genes
showed an unacceptable variable expression in our
model system, with values ranging from a 4.4-fold induc-
tion with TUB1 to a 23-fold induction with SDHA after
antifungal treatment. Altogether, these results suggest
that the choice of internal controls is highly specific to a
particular experimental condition, thus highlighting the
importance of validating reference genes for each experi-
mental model before commencement of RT-qPCR
studies.
Although it is now widely accepted that normalizing
to a single reference gene represents a strategy that is
simple to use and can control for every stage of the RT-
qPCR, some researchers also advocate the use of two or
more reference genes, rather than relying on a single
RNA transcript [9,10,44,59]. This is a robust method for
providing accurate normalization and is consequently
preferable when fine measurements are to be made.
According to Vandesompele et al. [9], the purpose of
normalization is to remove the sampling difference (such
as RNA quantity and quality) in order to identify realgene-specific variation. They provided evidence that a
conventional normalization strategy based on a single
gene can lead to erroneous normalization. However, it is
not always possible to measure multiple reference genes
because of limited sample availability and cost. Further-
more, even when multiple genes are chosen, the reso-
lution of the particular assay remains dependent on the
variability of the chosen reference genes. As to our case,
the geNorm analysis using the geometric mean of the
expression of the 16 candidate cDNAs suggested the use
of RDN5.8, RDN18, and RDN25 in combination or the
combination of these three ribosomal RNAs plus UBC13
and PGK1 as the reference control in the current study.
However, the geNorm assessment is based solely on the
variability of reference genes and does not take other
factors into account. For example, we found that al-
though RDN18 and RDN25 were quite stable, their amp-
lification efficiencies were not equal to the amplification
efficiencies of all target genes tested; thus, they may not
be suitable as internal controls in our system. Therefore,
when multiple reference genes are necessary, we believe
that the combination of RDN5.8 plus UBC13 and/or
PGK1 would be a better choice for quantitation of gene
expression by RT-qPCR in C. glabrata following azole
stimulation.
Conclusions
In this study, we evaluated 16 reference genes for poten-
tial use as internal controls for RT-qPCR analysis of gene
expression in C. glabrata (Cg84u strain) following 2
hours of exposure to fluconazole at 200 μg/ml. To our
knowledge, this is the first identification and validation
of RDN5.8, UBC13, and PGK1 as the most suitable and
stably expressed reference genes among the 16 reference
genes tested. Therefore, we recommend the use of
RDN5.8, UBC13, or PGK1 alone or the geometric mean
of these genes as standards for normalization when ana-
lyzing differences in gene expression levels in C. glab-
rata during antifungal treatment. More specifically,
RDN5.8 may be a more suitable reference gene for the
analysis of expression for genes with lower azole-
inducible mRNA levels, while UBC13 and PGK1 may be
better internal controls for quantifying the expression of
genes with higher azole-inducible mRNA levels in C.
glabrata. In contrast, we demonstrated that 10 reference
genes commonly used in published reports, including
ACT1, GAPDH, PPIA, RPL13A, and TUB1, had signifi-
cant differences in their expression upon azole challenge,
and thus were not validated as good endogenous con-
trols in this model. As a main conclusion, this study
emphasizes the importance of evaluation studies for the
selection of the most appropriate internal controls for
each experimental model used for quantitative expres-
sion studies.
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